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Introduction
Although endocytosis represents the prevailing route for the in-
ternalization of proteins into cells (D’Hondt et al., 2000; Itoh 
et al., 2001; Conner and Schmid, 2003), additional pathways have 
been suggested that only partially use or might even bypass the 
endocytic machinery. These pathways apparently facilitate the 
internalization of polybasic peptides such as magainin-2 and 
buforin (Matsuzaki et al., 1995, 1998; Takeshima et al., 2003), 
the HIV-1–based Tat protein, and the third helix of antennapedia 
from Drosophila melanogaster (penetratin), which mediates the 
transmigration of antennapedia through the plasma membrane 
and nuclear pore complex (Derossi et al., 1994; Joliot and 
 Prochiantz, 2004). Although the mechanisms supporting cellular 
incorporation might vary among the different types of cell-
penetrating peptides, membrane lipids could participate in sev-
eral of the proposed pathways (Mäe and Langel, 2006). Lipids 
are indeed capable of directly supporting the membrane passage 
of proteins as shown for the release of (apo)cytochrome c from 
mitochondria (Diekert et al., 2001; Kuwana et al., 2002).
Distinctive properties of the lipid architecture of the cell 
membrane include lateral microdomains enriched in cholesterol 
and (glyco)sphingolipids, which constitute a platform for signal 
transmission and the internalization of microorganisms (rafts 
and caveolae; Simons and Vaz, 2004; Jacobson et al., 2007). 
Another key feature of the plasma membrane is represented by the 
transverse asymmetry of lipids. Under specifi c biological condi-
tions, this asymmetry is attenuated, as exemplifi ed by the surface 
exposure of phosphatidylserine (PS), which provides a recogni-
tion signal for the phagocytosis of apoptotic cells (Gardai et al., 
2006) and establishes a catalytic surface for proteases impli-
cated in blood coagulation (Bevers et al., 1999). Under the same 
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Although their contribution remains unclear, lipids may facilitate noncanonical routes of protein in-ternalization into cells such as those used by cell-
penetrating proteins. We show that protein C inhibitor 
(PCI), a serine protease inhibitor (serpin), rapidly trans-
verses the plasma membrane, which persists at low tem-
peratures and enables its nuclear targeting in vitro and 
in vivo. Cell membrane translocation of PCI necessarily 
requires phosphatidylethanolamine (PE). In parallel, PCI 
acts as a lipid transferase for PE. The internalized serpin 
promotes phagocytosis of bacteria, thus suggesting a 
function in host defense. Membrane insertion of PCI de-
pends on the conical shape of PE and is associated with 
the formation of restricted aqueous compartments within 
the membrane. Gain- and loss-of-function mutations indi-
cate that the transmembrane passage of PCI requires 
a branched cavity between its helices H and D, which, 
according to docking studies, precisely accommodates PE. 
Our ﬁ ndings show that its speciﬁ c shape enables cell sur-
face PE to drive plasma membrane translocation of cell-
penetrating PCI.
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 conditions, the exposure of phosphatidylethanolamine (PE) is 
enhanced (Emoto et al., 1997; Smirnov et al., 1999). However, in 
contrast to the well-known functions of PS exposure, the func-
tional meaning of PE  externalization is largely unknown.
We found that the cellular internalization of the serpin pro-
tein C inhibitor (PCI) is crucially supported by plasma mem-
brane PE, which enables its rapid targeting to the nucleus both in 
vitro and in vivo. Our fi ndings position PCI as an eminent candi-
date for the nuclear supply of cargo. On the basis of the crystal 
structure of PCI, a hydrophobic cavity has been characterized as 
the binding site for PE, which is recognized by specifi c lipids of 
conical morphology. Our fi ndings indicate cell surface PE as a 
mediator for the cell membrane translocation of proteins and 
suggest that this requires the ability of the lipid to foster forma-
tion of transient nonbilayer domains within the membrane.
Results
PCI acts as selective transferase for PE
The lipid structure of the plasma membrane can be dynamically 
regulated by the selective insertion of extracellular lipids via 
specialized proteins such as scavenger receptor class B type I, 
which transfers cholesterol and phospholipids into cells (Acton 
et al., 1996; Urban et al., 2000), CD14, a transporter for phos-
phatidylinositol (Wang and Munford, 1999), and the fatty acid 
carrier CD36 (Koonen et al., 2005). These also include unknown 
proteins mediating the cellular import of PE (Engelmann et al., 
1998). To identify the latter proteins, we separated the superna-
tants from activated blood platelets by gel fi ltration. Then the 
phospholipid transfer activities of the fractions were measured 
by determining the exchange of fl uorescent-labeled phospho-
lipids between donor and acceptor vesicles. Among the fractions 
analyzed, fraction 23 caused the strongest stimulation of the 
 intervesicular transfer of fl uorescent-labeled PE (Fig. 1 A). 
 Because activated platelets secrete the PE- binding serpin PCI 
(Nishioka et al., 1998; Prendes et al., 1999), we analyzed whether 
fraction 23 contained this protein. PCI could indeed be detected 
in the active fraction (Fig. 1 A). The serpin was additionally re-
covered in the total supernatant (Fig. 1 A). To evaluate whether 
PCI was principally capable of mediating the PE transfer 
through aqueous media, the serpin was added to suspensions 
of labeled donor vesicles and unlabeled acceptor  vesicles. 
Figure 1. Identiﬁ cation of PCI as a lipid trans-
ferase promoting the cellular import of PE. 
(A) PCI is present in the platelet releasate frac-
tion with the highest PE transfer activity. (left) 
Supernatants from thrombin-activated human 
platelets were separated by gel chromatogra-
phy and the fractions were analyzed for their 
capacity to exchange py-PE between two types 
of SUV in vitro. (right) PCI is detected by a 
monoclonal anti-PCI antibody in the total super-
natant (S) and fraction 23 (F23) exhibiting 
the highest py-PE exchange activity (57- and 
54-kD forms of the serpin). (B) Acceleration of 
lipid exchange in vitro deﬁ nes PCI as a PE 
transfer protein. The py-PE transfer from donor 
vesicles to unlabeled acceptor vesicles was 
registered in the absence (●) or presence 
of 20 nM uPCI (■). Similar ﬁ ndings were 
obtained with rPCI (not depicted). (C) PCI se-
lectively enhances the cellular import of PE. 
Isolated human platelets were incubated at 
37°C for 10 min with uPCI and SUV contain-
ing the indicated py-phospholipids. Gray, con-
trol; black, PCI. n = 3–6. *, P < 0.05. (D) PCI 
supports cell uptake of [14C]PE. Platelet associ-
ated radioactivity was determined after incu-
bation with SUV (95:5% PC/PE; 14C-PE and 
3H-PC) without (control) or with uPCI (10 min, 
37°C). n = 5. *, P < 0.05 versus vesicle and 
control. (E) Facilitation of PE transfer increases 
thrombin formation. Platelets were challenged 
with 0.5 U/ml thrombin, a relatively weak stimu-
lator of the prothrombinase activity, which 
 nevertheless induces a robust secretion of PCI. 
In the presence of SUV containing PC alone 
(PC) or 5% PE plus 95% PC (PE; mol%), throm-
bin generation by the prothrombinase complex 
was evaluated with or without uPCI. Control 
experiments veriﬁ ed that no prothrombinase 
activity was elicited by the PE vesicles in the 
absence of platelets. An isotype control anti-
body did not inhibit the prothrombinase activity 
of activated platelets in the presence of PC/PE 
vesicles (not depicted). n = 4–6. *, P < 0.05. 
Results show mean values ± SD.
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Isolated PCI was found to transfer fl uorescent-labeled PE to the 
acceptor vesicles within short time periods (Fig. 1 B), which 
documents that the serpin supports the intermembrane exchange 
of PE. Moreover, PCI markedly augmented the incorporation of 
extracellular fl uorescent-labeled PE into platelets (Fig. 2 C) and 
several other cells (human monocytes, neutrophils, and umbilical 
vein endothelial cells; not depicted). However, PCI failed to en-
hance the incorporation of fl uorescent-labeled phosphatidyl-
choline (PC), sphingomyelin (Fig. 1 C, SM), and PS (not depicted). 
The enhanced PE uptake by the activated platelets was almost 
completely abolished by the anti-PCI antibody (Fig. S1, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200707165/DC1). 
Next, resting platelets were incubated with small unilamellar 
vesicles (SUV) containing 5% of total lipids on a molecular 
 basis (mol%) of PE (refl ecting the percentage of PE in human 
lipoproteins) and, additionally, [14C]PE + [3H]PC. In the ab-
sence of PCI, the [14C]PE/[3H]PC ratio remained unchanged 
compared with the ratio of the vesicles alone. In contrast, PCI 
augmented the [14C]PE/[3H]PC ratio, indicating that the serpin 
enhances [14C]PE transfer into platelets (Fig. 1 D). Hence, PCI 
promotes phospholipid import at physiological concentrations 
of extracellular PE. Insertion of PE into the platelet cell mem-
brane could infl uence the activity of the prothrombinase complex, 
which is known to be stimulated by cell surface PE (Billy et al., 
1995). Platelets were challenged with thrombin, a relatively 
weak stimulator of the prothrombinase activity, which neverthe-
less induces a robust secretion of PCI. Thrombin formation by 
the prothrombinase complex was profoundly enhanced when 
the PCI-mediated PE transfer into the platelets was operating 
(Fig. 1 E). In contrast, PCI failed to increase the thrombin gen-
eration when the lipid donors were devoid of PE. Control exper-
iments verifi ed that no prothrombinase activity was elicited by 
the PE vesicles in the absence of the platelets (unpublished 
data). The anti-PCI antibody abrogated the thrombin formation, 
which indicates that the secreted PCI is a responsible factor 
(Fig. 1 E). Additional PCI further promoted the thrombin for-
mation in the presence of the PE-containing donors but not with 
pure PC vesicles (Fig. 1 E). Our fi ndings characterize PCI as 
a selective lipid transporter for PE that supports the cellular 
 import of this phospholipid.
Rapid plasma membrane translocation and 
nuclear targeting of PCI
When visualizing the interaction of biotin-PCI with live HL-60 
cells, we found that several cells rapidly incorporated the protein. 
After 10 min, PCI accumulated in the submembraneous region 
(Fig. 2 A). Heparin cofactor II (HC-II), a serpin with sequence 
similarity to PCI, was not incorporated (see Fig. 5 C; not depicted). 
After longer incubation times, PCI was increasingly targeted to 
the nucleus. We indeed observed accumulation of PCI in the 
perinuclear space and intranuclear compartments by immuno 
EM (Fig. 2 B). Time-dependent accumulation of PCI was also 
seen in isolated cytosolic and nuclear fractions (Fig. S2, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200707165/DC1). 
The nuclear targeting of PCI might be facilitated by its H helix, 
because GFP-linked variants of PCI lacking the basic amino 
acids of this helix failed to enter the  nucleus (unpublished data). 
To explore whether the fast cell entry and nuclear targeting of 
the serpin was also operating in the intact organism, we injected 
biotin-labeled PCI into the tail vein of mice. The protein was 
 allowed to circulate for 30 min in the vascular system. There-
after, the total pool of leukocytes was prepared from the mu-
rine blood and cells were visualized by confocal microscopy. 
Thereby substantial costaining of PCI with the nuclear marker 
was noted in the granulocyte fractions (Fig. 2 C), which indi-
cates that the protein had been integrated into the nuclei. 
We thus conclude that the cell entrance of PCI enables its 
rapid targeting to intranuclear compartments both in vivo and 
in vitro.
Figure 2. Rapid cell entry and nuclear targeting of PCI. (A) Internalization 
of PCI into live cells. Leukocytic HL-60 cells were incubated for 10 min with 
90 nM of biotin-labeled uPCI (green) at 37°C, and intracellular staining of 
PCI was monitored by confocal microscopy at a focal plane allowing visu-
alization of nuclei. Cell nuclei were stained with TO-PRO-3 (red). The im-
ages are representative of ﬁ ve independent experiments. (B) Intracellular 
PCI is directed to intranuclear compartments. Immunoelectron micrographs 
of HL-60 cells incubated with 90 nM of biotin-labeled rPCI for 0 (control, 
immediately processed for the analyses) and 30 min at 37°C. Arrows indi-
cate PCI detected by gold-labeled anti-biotin antibody. No nuclear labeling 
of PCI is seen under control conditions. After 30 min of incubation, the ser-
pin accumulates in the nucleus (N). Bars, 0.5 μm. (C) PCI is targeted to 
leukocyte nuclei in vivo. Biotin-labeled uPCI injected into the murine blood 
circulation is recovered within 30 min in the nuclei of granulocytes. Co-
labeling of biotin-PCI with TO-PRO-3 in live granulocytes documents the 
nuclear localization of the serpin. 
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To quantify the cellular internalization of PCI, neutrophils 
were fi rst exposed to [125I]PCI followed by the addition of a 
 ligand dissociation buffer to exhaustively remove any proteins 
bound to the extracellular surface (Liu et al., 2000). Within the 
fi rst 2 min of incubation at 37°C, a large proportion of PCI accu-
mulated within the cells (Fig. 3 A). The incorporation then 
 proceeded at a slower rate. The quantity of PCI internalized at 
6°C amounted to 2/3 of the uptake at 37°C (Fig. 3 A). In contrast 
to the PCI internalization, the PE transferase activity of PCI was 
clearly diminished at low temperatures. Indeed, PCI failed to 
increase the [14C]PE/[3H]PC ratio at 6°C (Fig. 3 B). To further 
address the participation of endocytic routes, CHO cells were 
transfected with the K44A mutant of dynamin2 (Altschuler 
et al., 1998), which prevents the budding of vesicles necessary 
for internalization of cargo via several major endocytic routes. 
Intrusion of Alexa 488–PCI into K44A-transfected cells was 
only slightly lowered compared with the uptake observed in the 
wild-type cells (Fig. 3 C). Also, transfection with the AP180 
variant AP180-C selectively repressing the clathrin-mediated 
pathway barely reduced PCI incorporation (unpublished data). 
A major proportion of PCI incorporation thus persists under 
conditions suppressing the classic endocytic pathways. Inclusion 
of heparin into the cell suspensions to prevent interaction of PCI 
with the cell surface (Priglinger et al., 1994) substantially lowered 
the cell entry of PCI (Fig. 3 D). In contrast, the internalization 
was largely unaffected by receptor-associated protein, which 
blocks the function of the low-density lipoprotein receptor–
related protein (LRP/α2 macroglobulin receptor), a mediator 
of the uptake of Tat (Liu et al., 2000). Heparin also abrogated 
the PCI-mediated cellular import of [14C]PE, as is evident from 
its ability to prevent the PCI-elicited increase of the [14C]PE/
[3H]PC ratio (Fig. 3 E).
PE essentially supports the internalization 
of PCI
To evaluate the contribution of PE for the cell entrance of PCI, 
the cells were preincubated with duramycin, a cyclic peptide 
that specifi cally interacts with this phospholipid (Navarro et al., 
1985; Iwamoto et al., 2007). Duramycin dose dependently sup-
pressed incorporation of PCI at 37°C (Fig. 4 A). The peptide 
also diminished cell entry of PCI at 6°C (Fig. S3 A, available 
at http://www.jcb.org/cgi/content/full/jcb.200707165/DC1), 
suggesting that the pathway supporting PCI internalization was 
still functioning at this temperature. Then, before the addition 
of duramycin, cell surface proteins were excessively cleaved by 
trypsin/proteinase K. Even so, the capacity of the PE-binding pep-
tide to abrogate the PCI incorporation was maintained (Fig. S3 B). 
Although PE is a regular component of the external leafl et of the 
cell membrane (Zwaal and Schroit, 1997), its cell surface con-
tent increases under conditions of PS exposure. PCI can interact 
Figure 3. Internalization of PCI is largely 
 independent from temperature. (A) Restricted 
temperature dependence of the cell entrance 
of PCI. Uptake of 20 nM of 125I-labeled uPCI 
(125I-PCI) by neutrophils was assessed at 37 
(●) or 6°C (■). n = 3–5. (B) PCI fails to promote 
the cellular import of PE at 6°C. Neutrophils 
were incubated for 10 min with SUV (95 mol% 
PC and 5 mol% PE containing [14C]PE and 
[3H]PC) at the two indicated temperatures. 
 vesicle, [14C]PE/[3H]PC ratio in the absence of 
uPCI. n = 4. *, P < 0.05 versus vesicle (a) or 
PCI at 37°C (b). (C) PCI internalization is mostly 
conserved in cells with disrupted dynamin2 
function. Incorporation of Alexa 488–conjugated 
rPCI into CHO cells transfected with the dynamin2 
K44A variant (or with wild-type dynamin2) 
was quantiﬁ ed at 37°C. n = 4. (D) Heparin 
 inhibits PCI internalization. Neutrophils were 
incubated for 10 min at 37°C with 20 nM 
[125I]PCI. Interaction with the glycosamino-
glycans was prevented by 100 μg/ml heparin. 
Receptor-associated protein (RAP) was present 
at 0.4 μM. n = 4. *, P < 0.05 versus control. 
(E) Lipid transfer activity of PCI is decreased by 
heparin. Neutrophils were incubated with SUV 
containing [14C]PE and [3H]PC under conditions 
as in B. n = 3. *, P < 0.05 versus PCI alone. 
Results show mean ± SD.
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with both aminophospholipids (Malleier et al., 2007). To spec-
ify the interaction of PCI with PE in the presence of PS, we used 
fl uorescence correlation spectroscopy to calculate the diffusion 
coefficients of PCI bound to lipid vesicles and for free PCI 
(Fig. 4 B). The ratio of bound/free PCI amounted to 2.9 ± 0.2 
in the case of the PE/PC/PS vesicles, whereas it was 1.5 ± 0.1 
for the PC/PS vesicles (mean ± SD), indicating that the prefer-
ential interaction of PCI with PE persists in the presence of PS. 
To further evaluate the participation of PE for the internaliza-
tion of PCI, we added lipid vesicles enriched with high con-
centrations of PE. This decreased the PCI internalization to an 
appreciable extent (Fig. 4 C). Cell entry of the serpin remained 
unchanged, with vesicles containing exclusively PC. In the pres-
ence of extracellular PE, heparin was unable to further diminish 
the protein incorporation (Fig. 4 C). The latter fi nding estab-
lishes that heparin and extracellular PE abrogate the same route 
of PCI internalization. PCI thus elementarily necessitates PE 
for its passage through the cell membrane.
PCI is expressed in several body cavities (Geiger, 2007) 
and hence macrophages poised to clear invading microorganisms 
from these compartments are continuously exposed to the serpin. 
Resting macrophages exhibit increased aminophospholipid ex-
posure, which is enhanced during phagocytosis (Marguet et al., 
1999). We found that the rapid internalization of PCI by THP-1 
macrophages (unpublished data) was associated with an increased 
phagocytosis of Escherichia coli (Fig. 4 D). The effect was pre-
served when the phagocytes were fi rst allowed to incorporate 
PCI and then exposed to the bacteria. In contrast, preincubation 
of the bacteria with PCI before the addition of THP-1 cells 
reduced phagocytosis. PCI stimulated  phagocytosis of E. coli 
in cells in which the incorporation of the serpin was restricted 
to extranuclear regions of the cells, suggesting that the nuclear 
localization of PCI is not required for its ability to increase 
phagocytosis. Quantifi cation by fl ow cytometry confi rmed that 
PCI fosters the cell entry of bacteria (Fig. 4 E). Stimulation of 
phagocytosis was almost identical when PCI was removed 
Figure 4. Essential role of PE for the cellular 
internalization of PCI. (A) Cell entrance of PCI is 
abrogated by duramycin. Concentration depen-
dence of the inhibition of neutrophil [125I]PCI 
uptake (10 min, 37°C) by duramycin. Results 
show mean ± SD. n = 3–5. (B) PE increases 
membrane association of PCI in the presence 
of PS. Autocorrelation curves from ﬂ uorescence 
correlation spectroscopy measurements, repre-
senting the diffusion of Alexa 488–uPCI in 
proximity to membranes of GUV composed of 
30:65:5% PE/PC/PS (A) and 95:5% PC/PS 
(B). Curves C and D denote the diffusion of PCI 
in aqueous solution and of the hydrophobic 
probe DiD-C18 (D). Curves A and B could be 
ﬁ tted by diffusion coefﬁ cients corresponding to 
the protein diffusion in the membrane environ-
ment and the aqueous solution. The shift to 
the right indicates that more PCI molecules 
are membrane associated in the case of PE-
containing vesicles. The data are representa-
tive of seven experiments. (C) Extracellular PE 
inhibits the cell entry of [125I]PCI. SUV contain-
ing 100% PC or 30% PE and 70% PC were 
included into the neutrophil suspensions. Results 
show mean values ± SD. n = 4–6. *, P < 
0.05 versus PC. (D) PCI enhances cellular up-
take of E. coli. uPCI and FITC-labeled E. coli 
were incubated with live THP-1 macrophages. 
In other samples, the cells were preincubated 
for 30 min before the addition of bacteria 
or with the bacteria before addition of cells. 
The confocal microscopy pictures show mostly 
intracellular bacteria. The images are repre-
sentative of three independent experiments. 
(E) Quantiﬁ cation of increased phagocytosis 
via PCI. (top) Representative experiment show-
ing the uptake of FITC-labeled E. coli as quanti-
ﬁ ed by ﬂ ow cytometry. Where indicated, the 
cells were selectively preincubated with PCI, 
washed, and further incubated with bacteria. 
Inhibition by cytochalasin D (CytoD) indicates 
that uptake of E. coli occursby phagocytosis. 
(bottom) Phagocytosis is displayed as a per-
centage of FITC-positive macrophages (mean 
values of duplicates). b and m, PCI preincubated 
with bacteria and macrophages, respectively. (F) Stimulation of phagocytosis requires PCI–PE interaction. THP-1 macrophages were preincubated with or 
without uPCI in the absence or presence of 0.5 μM duramycin. The cells were washed once and FITC-labeled E. coli was added. The intracellular localization 
of the bacteria was visualized by confocal microscopy. The images are representative of three independent experiments.
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after  preincubation, whereas preincubation of PCI with bacteria 
suppressed their uptake (Fig. 4 E). This shows that stimulation of 
phagocytosis by PCI requires a direct interaction of the serpin 
with the cell membrane. Pretreatment of the macrophages with 
PCI in the presence of duramycin, which also inhibited PCI inter-
nalization into THP-1 cells (not depicted), decreased cell entry of 
E. coli (Fig. 4 F). In contrast, basal uptake of bacteria (absence of 
PCI) was unaffected by duramycin (Fig. 4 F). Hence, the specifi c 
membrane partitioning of PCI facilitates bacterial phagocytosis.
Membrane insertion of PCI is facilitated by 
cone-type lipids
Because several of the translocating peptides were previ-
ously shown to generate transmembrane pores (magainin-2 and 
mastoparan X; Matsuzaki et al., 1995; Schwarz and Arbuzova, 
1995), we investigated whether PCI elicited pore formation. 
As a positive control, the peptide mastoparan X rapidly evoked 
nucleation of pores in large unilamellar vesicles (LUV; Fig. 5 A), 
as was evident from the leakage of intravesicular carboxyfl uo-
rescein (CF). In contrast, PCI did not elicit the formation of 
leakage sites for CF (Fig. 5 A), even after prolonged incubation 
(up to 120 min; not depicted). To evaluate whether PCI altered 
the membrane barrier properties for a small hydrophilic mole-
cule, we monitored the membrane passage of the cation praseo-
dymium (Pr3+; Sillerud and Barnett, 1982). By using 31P nuclear 
magnetic resonance (NMR), two peaks originating from the 
phosphate groups of the outer and inner monolayer phospho-
lipids could be discerned (Fig. 5 B). In LUV containing solely 
Figure 5. PCI translocation is facilitated by cone-shaped lipids supporting formation of intramembrane aqueous compartments. (A) PCI does not cause 
pore formation in membranes. CF was included in the aqueous core of LUV (30:70% PE/PC), and, subsequently, 0.5 μM rPCI or 4 μM mastoparan X 
(positive control) was added. Mastoparan X, but not PCI, induces the CF release. (B) PCI enables slow membrane translocation of a small hydrophilic 
molecule. 31P-NMR spectra were recorded 300 min after addition of 5.7 mM Pr3+ and 40 nM uPCI (C and D) to the vesicle suspensions. (A and C) 
LUV with 30:70% PE/PC. (B and D) 100% PC. The decrease in intensity caused by line broadening of the phosphorous signal from the inner leaﬂ et at 
3 ppm (C) indicates cation inﬂ ux into the vesicles. (C) Membrane partitioning of PCI. (top) 20 nM rPCI is accessible to intravesicular 0.5 mg/ml trypsin 
(37°C) in LUV containing long chain PE but not in pure PC vesicles. (bottom) Under the same conditions, HC-II remains uncleaved. (D) Cone-type lipids 
enforce membrane penetration of PCI. LUV were prepared from the indicated lipids, the vesicle matrix being PC (adding up to 100 mol%). After incuba-
tion with rPCI, 0.5 μg/ml trypsin was added. Part of the PCI remains unfragmented when the vesicles contain long chain PE and DAG but not with 
short chain PE or PS. (E) PCI reaches the aqueous core of lipid vesicles. Proteinase K in LUV supplemented with PE and DAG affords complete degrada-
tion of rPCI, indicating its protrusion into the vesicle interior. Conversely, the integrity of the protein is fully preserved in pure PC-LUV. Control cleavage 
(absence of vesicles) reveals complete PCI degradation (all cleavage products <15 kD). All protease experiments were repeated at least once.
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PC, the peak pattern was unchanged by prolonged incubation 
with the cation. However, the addition of PCI markedly reduced 
the height and broadened the peak representing the inner leafl et 
phospholipids when long chain PE was present (Fig. 5 B). This 
demonstrates a direct interaction of Pr3+ with the inner mono-
layer phospholipids. As a negative control, no changes in the 
 inner monolayer peak were seen without PCI. PCI thus generates 
transient and subtle changes in the bilayer structure that result 
in the formation of an aqueous pathway within the membrane.
To evaluate whether PCI itself is inserted into the mem-
brane, we added trypsin into the vesicle core. Whereas the ser-
pin remained largely uncleaved by the intravesicular protease in 
pure PC vesicles, it was clearly degraded when the membrane 
contained long chain (unsaturated) PE (Fig. 5 C). In contrast to 
PCI, the integrity of HC-II was fully conserved in the presence 
of the intravesicular trypsin, irrespective of the lipid composi-
tion of the vesicles (Fig. 5 C). In a complementary procedure, 
PCI was fi rst incubated with the lipid vesicles and subsequently 
treated with extravesicular trypsin. In the presence of PE, part of 
the PCI remained refractory toward cleavage by the extravesicu-
lar trypsin (Fig. 5 D). In contrast, PCI was completely degraded 
in suspensions of the pure PC and PC/PS vesicles. The ability of 
PCI to penetrate into the bilayer thus crucially requires PE.
Partitioning of PCI into the lipid bilayer could be facili-
tated by a specifi c binding to PE (e.g., via interactions with the 
ethanolamine head group) and/or changes in the physicochemical 
properties of the membrane. In the latter case, nonbilayer  domains, 
which are particularly favored by the conical shape of PE, could 
be involved (Israelachvili, 1980; de Kruijff, 1997). When the LUV 
were prepared from a short chain species of PE with a cylindrical 
morphology (di-14:0-PE), the protein was entirely degraded by 
extravesicular trypsin, similar to the fi ndings obtained with the 
pure PC vesicles (Fig. 5 D). However, in LUV consisting of a 
lipid with a conical confi guration but devoid of the ethanolamine 
head group DAG, PCI was partially resistant toward cleavage by 
the protease (Fig. 5 D). This suggests that the conical shape of 
long chain PE is essential for the membrane penetration of PCI. 
To further substantiate the extent of membrane insertion of the 
serpin, we exploited the ability of proteinase K to excessively 
degrade the serpin (Fig. 5 E). When the protease was integrated 
into the aqueous core of vesicles containing long chain PE, PCI 
was cleaved into several high molecular mass degradation pro-
ducts (Fig. 5 E), confi rming that PCI protrudes into the vesicle 
core. In LUV supplemented with DAG, very similar fragmenta-
tion products were apparent. Conversely, after inclusion of the 
protease into vesicles only consisting of PC, the integrity of 
the protein was fully conserved (Fig. 4 E). This confi rms that the 
 serpin failed to reach the vesicle core in the presence of PC alone. 
Overall, our fi ndings suggest that the conical shape of long chain 
PE is essential for the membrane penetration of PCI, which 
adopts a location that completely spans the bilayer.
PCI translocation requires key components 
of the hydrophobic pocket allowing 
selectivity of lipid interaction
Molecular docking studies based on the crystallographic struc-
ture of PCI (Huntington et al., 2003) were undertaken to charac-
terize the structural components of PCI enabling its distinctive 
interaction with phospholipids. In view of the fl exibility of the 
entire PE molecule, we chose a rigid fragment of the saturated 
hydrocarbon chain (C11 fragment) for the initial docking analy-
sis because saturated fatty acyl chains are esterifi ed to the C1 
atom of the glycerol backbone of (diacyl-)PE under biological 
conditions (Fig. S4, available at http://www.jcb.org/cgi/content/
full/jcb.200707165/DC1). Docking of the C11 fragment onto 
the PCI structure revealed 276 clusters with energies (kJ/mol) 
better than −15 among a total of 25,242,070 calculations. The 
two best clusters were nearly identical in position and energy 
(both better than −28 kJ/mol) and were signifi cantly separated 
from the other clusters, with the next best hit at −24.3 kJ/mol. 
The best-docked C11 fragment fi t into a capped hydrophobic 
pocket along helix D (D′ channel; Fig. 6 A). The orientation of 
the saturated chain was thus fi xed. Consequently, the possible 
positions of the unsaturated chain, canonically esterifi ed to the 
C2 atom of PE, were spatially limited to the same region. Of the 
top 10 clusters, two provided a portion of the possible binding 
site for the unsaturated hydrocarbon chain (9th and 10th best 
energies). It was found to be best accommodated by a second 
hydrophobic channel running along helix H (H′ channel), in 
close proximity to the PCI-binding site for heparin (Figs. 6 A 
and S4, helix H). Moreover, in view of the locations revealed for 
the acyl chains, the position of the head group of PE was also 
suggested. The entire PE molecule was built on the two hydro-
carbon chains placed by the docking studies and subjected to 
energy minimization. In the fi nal model (Fig. 6 A), the ethanol-
amine group is found to be located in close proximity to Leu78, 
whereby the formation of an H bond between the N atom of the 
ethanolamine group and the main chain oxygen of Leu78 could 
be enabled. Space limitations within this region principally im-
pair the interaction of PCI with phospholipids containing larger 
head groups than PE such as PC.
To explore the role of the hydrophobic pocket for the 
PE-dependent membrane insertion of the serpin, PCI residues 
 potentially implicated in the lipid binding were mutated. L78 
was substituted by Trp to prevent the proposed interaction of 
the protein with the ethanolamine head group. Consequently, the 
variant remained completely undigested in the presence of the 
intravesicular proteinase K, oppositely to the native protein (Fig. 
6 B). Substitution of V374, a component of the H′ channel sug-
gested to mediate the binding of the sn-2 fatty acyl chain of PE, 
by Trp also conferred resistance toward cleavage by the intra-
vesicular protease (Fig. 6 B). Both amino acid  exchanges thus 
suppress the ability of PCI to partition into the vesicle core. 
In contrast, mutations of residues R35 and T341, both being un-
related to the proposed lipid binding site, did not perturb the PCI 
penetration into the vesicle center (unpublished data). A qualita-
tively different digestion pattern was noted when three Ala were 
inserted at position 376 (Fig. 6 B). This insertion was imple-
mented to restitute the loop between the last two β strands spe-
cifi cally truncated in PCI while attenuating its hydrophilic 
properties. Part of the PCI species was accessible by the intra-
vesicular enzyme, as was evident by the appearance of digestion 
products (Fig. 6 B), arguing for its protrusion into the vesicle 
core. To further detail the extent of membrane penetration, the 
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variant was exposed to extravesicular proteinase K. Thereby, the 
mutant remained almost entirely refractory toward proteolytic 
attack (Fig. 6 C). In contrast, under the same conditions, the 
complete loss of the substrate and limited cleavage into a single 
high molecular mass degradation product was noted for the 
 native protein (Fig. 6 C). The differential digestion pattern for 
the wild-type PCI in the presence of the intra- versus extravesic-
ular protease (Fig. 6, B and C) excluded a passage of the enzyme 
across the bilayer. The fi ndings thus suggest that the 376AAA 
insertion strongly facilitates the membrane translocation of PCI. 
This conclusion was enforced by experiments with intact cells. 
After a 10-min incubation period, the labeled 376AAA variant 
was found to be rapidly internalized by HL-60 cells (Fig. 6 D). 
In particular, during the short exposure, a noticeable proportion 
of the mutant was incorporated into the nucleus (Fig. 6 D), in 
contrast to what had been observed with the native serpin (Fig. 
2 A). Overall, the fi ndings establish that the branched hydro-
phobic cavity in between helices H and D is of basic importance 
for the membrane insertion and transmigration of PCI.
Discussion
We demonstrate that the internalization of a new cell-penetrating 
protein, the serpin PCI, is essentially supported by the plasma 
membrane lipid PE. Lipids are known to contribute to the inter-
action and insertion of proteins into intracellular and bacterial 
membranes (van Klompenburg et al., 1998; Kuwana et al., 2002). 
However, their contribution to the protein insertion into the 
plasma membrane and consequently the protein internalization 
into cells is less well documented. Our fi ndings now reveal that 
cell surface–exposed PE is a major mediator of the protein trans-
location across the plasma membrane. The essential contribu-
tion of PE is corroborated by the ability of the PE-binding 
peptide duramycin to abrogate protein uptake, the failure of the 
serpin to cross the cell membrane in the presence of extracellu-
lar PE, and the selective PE requirement for membrane penetra-
tion of PCI. Interaction of PCI with PE is preceded by docking 
of the serpin to negatively charged surface molecules such as 
glycosaminoglycans. This suggests that two basic steps, initial cell 
surface docking and subsequent interactions with PE, mediate 
the membrane insertion and cell entry of the protein. Importantly, 
we show that the distinct conical shape of PE (Israelachvili et al., 
1980; de Kruijff, 1997) represents a major driving force for the 
membrane translocation of PCI.
PE is the eminent plasma membrane lipid with a cone-type 
morphology because the concentrations of similarly shaped 
 lipids (DAG and phosphatidic acid) are considerably lower. 
Mechanistically, DAG also effi ciently supported the membrane 
penetration of PCI, whereas the protein intrusion was prevented 
by cylindrical PE species. This suggests that the conical shape of 
PE is of greater relevance for the interaction with PCI than spe-
cifi c interactions with the ethanolamine head group. Despite the 
bilayer-spanning location of PCI, the protein was not entirely 
transferred to the vesicle core, suggesting that its incorporation 
into the cell interior requires additional membrane components. 
Moreover, although transmembrane pores were not implicated 
in the PCI translocation, which is consistent with the inability of 
the conical lipids to support the pore formation (Matsuzaki et al., 
1998), the serpin was found to elicit subtle perturbations of the 
membrane organization, as indicated by the leakage of ions from 
the lipid vesicles. This indicates that the PCI–PE interaction induces 
the formation of aqueous  compartments within the membrane. 
Figure 6. Hydrophobic cavity accommodating PE drives protein trans-
location. (A) Energy-minimized model of PE bound to PCI. The model is 
based on the two hydrocarbon docking solutions shown in Fig. S4 (avail-
able at http://www.jcb.org/cgi/content/full/jcb.200707165/DC1). The 
positions of the H and D helices are indicated as are the channels after 
which they are named. The close up demonstrates the suitability of this fea-
ture of PCI for binding to diacyl phospholipids. Moreover, the positions of 
the amino acids are indicated subjected to mutagenesis in B–D. Green in-
dicates hydrophobic areas of the protein. (B) Amino acid substitutions of 
the proposed lipid binding site impair PCI translocation. Native and muta-
genized PCI species (20 nM) were incubated with PE vesicles containing 
intravesicular proteinase K. Contrary to the native protein, mutations in the 
head group and fatty acid–binding regions (L78W and T374W) prevent 
the protein from degradading, indicating incomplete incorporation into the 
bilayer. The 376AAA insertion mutant is strongly digested, which suggests 
its full penetration into the bilayer. (C) 376AAA insertion enhances mem-
brane intrusion of PCI. In the presence of extravesicular proteinase K, the 
full-length form of native PCI is completely lost. In contrast, the 376AAA 
 insertion is resistant to fragmentation by the protease, conﬁ rming the dis-
appearance of the variant from the extravesicular compartment. (D) PCI vari-
ant 376AAA is rapidly directed to intranuclear compartments. HL-60 cells 
were incubated for 10 min with 90 nM of the biotin-labeled PCI variant 
(green) at 37°C and analyzed by confocal microscopy. In parallel, cell 
 nuclei were stained with TO-PRO-3 (red). 
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Lipids of cone-type morphology are principally capable of gen-
erating areas of negative curvature in membranes (Farsad and 
De Camilli, 2003). This can facilitate the formation of intra-
membrane nonbilayer domains (inverted micelles), which might 
assist in the formation of aqueous compartments within the 
membrane. At present, it is unclear how the PCI–PE interaction 
mediated by the docking of the lipid to a distinct hydrophobic 
groove in PCI in the molecular system (see last paragraph of 
Discussion) relates to the alterations in physicochemical prop-
erties by the cone-shaped lipids that allow PCI transfer across 
the membrane. Hence, more in-depth analyses will be required 
in future studies to clarify whether these two observations are 
indeed interrelated. Overall, our results indicate that the mem-
brane passage of PCI is crucially driven by lipids of a distinct 
morphology that generate an aqueous translocation route for the 
protein via the generation of nonbilayer domains.
The lipid-dependent internalization of cell-penetrating PCI 
principally agrees with a model theoretically proposed for the 
internalization of the translocating peptides (Joliot and Prochiantz, 
2004). However, a contribution of PE and its peculiar shape for 
the cellular uptake of proteins has never been revealed. Cone-
shaped lipids faciliate membrane fusion and budding processes 
(McMahon and Gallop, 2005), which are required for the forma-
tion of phagosomes. Consequently, the enhancement of bacterial 
phagocytosis induced by the PCI–PE interaction as observed here 
could be enabled by the stimulation of phagosome maturation. 
The ability of PCI to foster removal of pathogens suggests its 
participation in host defense and thus overlaps with the functions 
of other cell-penetrating proteins implicated in innate immunity. 
The internalized PCI was found to be rapidly directed to the 
nucleus, both in vitro and in the intact organism. Our fi ndings 
position PCI as a promising candidate for the rapid delivery of 
cargo to the nucleus, including viruses, nucleotides of differing 
length and structures, and proteins/peptides. Being a component 
of the human proteome, potential applications of cargo-loaded 
PCI in humans are not immunogenic. PCI might be exploited in 
particular for the targeting of cargo into cells with increased sur-
face exposure of PE (Vance, 2003), including capacitated sperm 
(Gadella and Harrison, 2000) and others.
PCI is shown to selectively extract PE from lipid particles, 
consecutively inserting the lipid into the plasma membrane of 
various cells. PCI thus belongs to a new class of proteins pro-
moting the cellular uptake of selective lipids, including those 
specifi c for phosphatidylinositol (Wang and Munford, 1999) 
and sphingoymyelin (Stoeckelhuber et al., 2000). The latter pro-
teins do not share structural homologies with PCI, a situation 
known from the intracellular lipid transfer proteins (Wirtz, 1997). 
During the transfer, the phospholipid would have to be largely 
protected from the contact with water, as revealed for scavenger 
receptor class B type I, the prototype mediator of the cellular 
phospholipid import (Urban et al., 2000). Based on the velocity, 
extent, and temperature dependence of the PE import, we assume 
that a principally similar process allows PCI to ferry PE into the 
cells. Only a limited change in the conformation of the protein–
lipid complex might be required to switch between the extra- 
and intramembrane modes of the PCI–PE interaction. Indeed, 
the protein is most likely integrated into aqueous compartments 
during the membrane translocation. Nonetheless, at low tem-
peratures, the lipid transferase activity of PCI is suppressed, 
whereas the PE-dependent PCI internalization is largely main-
tained. This indicates that the PE transfer is energy independent, 
whereas the membrane translocation of PCI exhibits a limited 
energy requirement, a property common to several cell-penetrating 
proteins. Whereas PCI facilitates PE enrichment on the cell sur-
face by virtue of its lipid transferase activity, PE accumulation 
is further assisted by the delayed transbilayer movement of 
the lipid (Morrot et al., 1989). We observe that PE insertion 
 accelerates the activity of the prothrombinase complex, thereby 
amplifying the formation of thrombin, a major coordinator of 
blood coagulation. Once internalized, PCI could potentially also 
support the intracellular movement of PE, such as between the 
cell membrane and membranes of intracellular organelles. Over-
all, our fi ndings characterize PCI as the fi rst transferase specifi -
cally fostering the cell import of PE.
Using the crystal structure of PCI as a template, we re-
vealed that the selective interaction of PCI with PE is facilitated 
by a dual-channelled hydrophobic groove that is generated by 
the shortened A helix and a truncated loop between strands 3 and 
4B. The H′ and D′ channels arising therefrom accommodate the 
extensions of the fatty acyl chains of the phospholipid with sharp 
precision. Indeed, because the H′ channel is not capped, it can 
house hydrocarbon chains of up to 22 C atoms, the longest un-
saturated fatty acids esterifi ed to PE in mammals. Moreover, the 
restricted size of the structure in which the phospholipid head-
group is buried markedly favors interactions with conical phos-
pholipids. Hydrogen bonds between the ethanolamine group and 
specifi c amino acids, suggested to permit the folding of bacterial 
lactose permease (Bogdanov et al., 1999), might additionally 
ease the interaction with the phospholipid, as exemplifi ed by the 
functional contribution of Leu78. Together, this structural con-
stellation is supposed to enable the higher affi nity of PCI for PE 
over PC. The docking and energy minimization studies were 
corroborated by the mutagenesis of single amino acids designed 
to specifi cally remodel the hydrophobic cavity. In particular, the 
insertion of a triple Ala sequence on top of the H′ channel sub-
stantially promoted the intrusion and membrane translocation of 
the serpin. The insertion, which reconstitutes the truncated loop 
intercalated between strands 3 and 4B, is likely to strengthen 
the interaction with the fatty acyl chains of the phospholipids 
by virtue of its specifi c location and enhanced hydrophobicity. 
In conclusion, the hydrophobic pocket appears to represent a 
unique structure for accommodating lipids capable of support-
ing the membrane passage of proteins.
Materials and methods
Cells
Human platelets were isolated from citrated blood as described previously 
(Engelmann et al., 1998). For isolation of neutrophils, the buffy coats from 
human blood anticoagulated with citrate were incubated with microbeads 
coupled to anti-CD15 antibodies for 15 min at 8°C. The suspensions were 
applied onto the positive selection column (Miltenyi Biotech) and the neu-
trophils were eluted with buffer. The purity of the neutrophil suspensions 
was >95% and the viability of the cells was 98% (trypan blue exclusion). 
CHO cells were transfected with pcDNA3 wild-type dynamin2 and its 
dominant-negative K44A mutant (provided by S. Egan, The Hospital for 
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Sick Children, Toronto, Canada). Cells were cultured in Iscove’s modiﬁ ed 
Dulbecco’s medium containing 20% FBS (HL-60) or DME supplemented 
with 10% FCS (CHO).
Preparation of native PCI and PCI variants
For preparation of recombinant PCI, the cDNA of human PCI was ampliﬁ ed 
from a human liver cDNA library using a forward (5′-C C G C T C G A G C A T A T G-
C A C C G C C A C C A C C C C C G G G A G -3′) and reversal primer (5′-C G G G A T C C-
A T C A T C A G G G G C G G T T C A C T T T G C C A A G -3′). Mutagenesis was performed 
using the QuickChange site-directed mutagenesis kit (Stratagene). The follow-
ing mutants were generated: V374W, T341R, L78W, R35A, and 376AAA. 
All mutations were conﬁ rmed by DNA sequencing. After transformation of 
E. coli with the plasmids, 0.4 mM IPTG was added to induce the expression 
of the proteins. Bacterial supernatants were applied to a TALON Metal Afﬁ nity 
Resin column (Clontech Laboratories, Inc.) and the fractions eluted from the 
column were analyzed by SDS-PAGE. Urinary PCI (uPCI) was puriﬁ ed as 
 described previously (Priglinger et al., 1994).
Phospholipid exchange
For the determination of the intervesicular phospholipid exchange, py-
 labeled donor vesicles and unlabeled acceptor vesicles were coincubated 
for different time periods, the suspensions were passed over an anion ex-
change column (Bio-Rad Laboratories), and the ﬂ uorescence was deter-
mined in Triton X-100 (Sigma-Aldrich) solubilisates of the acceptor vesicles 
as described previously (Stoeckelhuber et al., 2000). The vesicle prepara-
tions and incubations were performed in the presence of 10 nM butylated 
hydroxytoluene and under argon or nitrogen. The transfer of py-labeled 
phospholipids into the cells was analyzed as described previously (Urban 
et al., 2000). Under principally similar conditions, the cells were incubated 
with lipid donor vesicles containing traces of [14C]PE (1-palmitoyl, 2-lino-
leoyl species) and [3H]cholesterol (both from GE Healthcare).
Confocal microscopy
Washed HL-60 cells and murine leukocytes (see Incorporation of PCI…) 
were incubated with biotin-labeled PCI at 6 or 37°C. The cells were ﬁ xed 
with 4% paraformaldehyde for 60 min at room temperature, permeabi-
lized with 0.1% Triton X-100 in 0.1% sodium citrate for 2 min at 4°C, and 
washed thereafter. Nonspeciﬁ c binding sites were saturated overnight at 
4°C with antibody dilution buffer (Dako) containing 0.2% goat serum. Sub-
sequently, the cells were incubated for 60 min with Cy-2–labeled streptavi-
din (GE Healthcare) and an additional 30 min with TO-PRO-3 (Invitrogen). 
The cells were transferred onto slides and covered with Vectashield (Vector 
Laboratories). Slides were analyzed at room temperature with a laser scan-
ning microscope (LSM 510 Meta; Carl Zeiss, Inc.) using a Plan-neoﬂ uar 
40×, 1.3 oil differential interference contrast 1056–602 (1083–997) 
objective lens (Carl Zeiss, Inc.) and 488-nm Ar2 and 633-nm HeNe2 lasers. 
Images were obtained with a PMT photomultiplier tube (Hamamatsu 
Photo nics). Image acquisition and processing was performed with LSM 
510  image examiner software (Carl Zeiss, Inc.).
For analysis of phagocytosis of E. coli into THP-1 macrophages, the 
cells (105/well) were seeded in 24-well plates in 500 μl RPMI-1640 sup-
plemented with 10% heat-inactivated FCS, 1% Hepes, 500 U/ml penicil-
lin, and 500 μg/ml streptomycin and differentiated by the addition of 10 nM 
PMA. After 16 h, the cells were fed with fresh, PMA-free medium and culti-
vated for two more days. The macrophages were incubated with Alexa 
488–labeled uPCI or FITC E. coli alone or together with their nonﬂ uores-
cent counterparts in serum-free medium. Some samples were treated with 
duramycin (Sigma-Aldrich) for 15 min before the start of the incubations. 
The samples were visualized with a confocal laser scanning microscope 
(LSM 510 META). The images were taken by using a 63× Plan-Apochro-
mat oil objective (Carl Zeiss, Inc.). Alexa 488 and FITC were irradiated at 
488 nm and detected via a 505 longpass ﬁ lter (Carl Zeiss, Inc.). The im-
ages obtained were analyzed and quantiﬁ ed using LSM Image Browser 
software (Carl Zeiss, Inc.).
Immuno EM
HL-60 cells previously incubated with or without 90 nM of biotin-labeled 
PCI were washed and ﬁ xed with 4% paraformaldehyde/5% glutaralde-
hyde for 60 min at room temperature. Before embedding in LR white me-
dium resin (Pelco), the HL-60 cells were ﬁ xed with 2.5% glutaraldehyde in 
0.1 M cacodylate buffer and then rinsed in 0.1 M phosphate buffer. Ultra-
thin serial sections of 150 nm were cut and mounted on gold grids. Non-
speciﬁ c binding sites on the sections were blocked with 5% BSA in PBS, 
and grids were incubated for 120 min at 37°C with 10 nm of gold-labeled 
goat anti-biotin IgG (Biocell Laboratories, Inc.). The sections were then 
counterstained with 3% uranyl acetate and lead citrate and examined with 
a transmission electron microscope (JEM TEM 1200 EXII; JEOL Ltd.).
Incorporation of PCI by murine leukocytes in vivo
4 μg of biotin-labeled recombinant PCI (rPCI) was injected into the tail vein 
of anaesthetized mice. After 30 min, blood was drawn from the periorbital 
sinus into 0.38% sodium citrate, immediately diluted by 1:10 with erythro-
cyte lysis buffer (155 mM NH4Cl, 10 mM KHCO3, and 0.1 mM EDTA, pH 
7.4), and centrifuged at 400 g for 20 min. The pellets were washed three 
times with decreasing volumes (1.5, 0.5, and 0.1 ml) of erythrocyte lysis 
buffer. The leukocytes obtained were processed for confocal microscopy as 
described previously.
Phagocytosis assay
THP-1 cells were differentiated with PMA as described in Confocal micros-
copy. Subsequently, the cells were washed in serum-free medium, mixed 
with 2 × 107 FITC-labeled E. coli (Vybrant Phagocytosis Assay kit; Invitro-
gen) in a ﬁ nal volume of 500 μl, and incubated for 2 h at 37°C in the pres-
ence or absence of 100 nM uPCI, 50 μM cytochalasin D, or 10% (vol/vol) 
human serum. In the preincubation experiments, either macrophages or 
bacteria were separately preincubated with 100 nM uPCI in serum-free 
medium for 60 min at 37°C and washed once before being added to the 
phagocytosis assay. After 2 h, noninternalized bacteria were rinsed away 
(after rinsing ﬂ uoroscence images were taken) and loosely attached E. coli 
were removed by trypsinization. The phagocytes were collected by centrif-
ugation, resuspended in ice-cold PBS, and analyzed by ﬂ ow cytometry 
(FACSCalibur; BD Biosciences).
Quantiﬁ cation of cellular internalization of PCI
uPCI was labeled with 125I (GE Healthcare) by adding 100 μCi of the 
isotope to 50 μl of 0.25 M sodium phosphate buffer, pH 7.0, followed by 
the immediate mixing with 10 μl of 5 mg/ml chloramine T solution. 5 min 
after addition of 2.5 μg PCI, the reaction was stopped by inclusion of 50 μl 
of a saturated sodium ascorbate buffer, pH 7.0, and the labeled protein 
was puriﬁ ed from the unreacted 125I via passage over a Sephadex-G10 
column (GE Healthcare). After incubation with the labeled PCI, the cells 
were washed once with PBS and incubated for 30 min at 4°C with ligand-
dissociation buffer (0.05% trypsin, 0.5 M EDTA, and 50 μg/ml proteinase K 
in PBS; Liu et al., 2000). The suspensions were centrifuged, the extracellular 
media were discarded, and the radioactivity of the pellets was determined. 
Alexa ﬂ uorescence intensity was measured in detergent-treated pellets 
(2% Triton X-100).
Prothrombinase activity
The activity of the prothrombinase complex was determined as described 
previously (Zieseniss et al., 2001).
Western blots
HL-60 cells were incubated with 100 nM PCI at 37°C, and the cell pellet 
was resuspended in nuclear extraction buffer 1 (10 mM Tris-HCl, 10 mM 
KCl, 0.5% IGEPAL CA-630, and protease inhibitor cocktail Complete; 
Roche), incubated for 30 min on ice, and lysed by sonication. The super-
natants obtained from the homogenates were centrifuged and the resulting 
supernatants were used for separation of the cytosolic proteins. The pellets 
of the homogenates containing the nuclei were resuspended in extraction 
buffer 2 (10 mM Tris-HCl, 0.5M NaCl, and Complete), incubated for 
30 min on ice, and centrifuged for 30 min, and the supernatants were 
recovered. After 10% SDS-PAGE, the proteins were transferred onto poly-
vinylidene ﬂ uoride membranes (Millipore), blocked overnight with 5% dry 
milk, and incubated for 60 min with anti-PCI antibody. After incubation 
for 45 min with horseradish peroxidase–conjugated anti–rabbit IgG, the 
proteins were visualized.
Translocation of PCI across pure lipid membranes
LUV were prepared from 10 mg of total lipids per milliliter in a buffer com-
posed of 20 mM Hepes and 150 mM NaCl, pH 7.5, and supplemented 
with 0.5 mg/ml trypsin or 0.1 mg/ml proteinase K (intravesicular prote-
ases). The various lipids (1-palmitoyl, 2-linoleoyl species of PC and PE, 
 dimyristoyl-PE, dioleoyl-DAG, and PS) were dispersed by vortexing with 
glass beads. They were passed several times through an extruder (100 or 
200 nm ﬁ lters; LiposoFast; Avestin) until the solution was clear. The vesicle 
suspensions were subsequently dialyzed. Then the vesicle suspensions were 
incubated with PCI for 60 min at 37°C. The vesicle preparations and incu-
bations were performed in the presence of 10 nM butylated hydroxytoluene 
under argon or nitrogen. Incubations with the intravesicular  proteases 
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were performed in the presence of 2 mM of the protease inhibitor PMSF. 
Where indicated, the preparation of the LUV was performed before the 
proteases, and trypsin or proteinase K were added after the incubations 
with PCI (extravesicular proteases).
Efﬂ ux of CF from LUV
The lipids were dispersed in a buffer composed of 10 mM Hepes, 100 mM 
KCl, and 1 mM EDTA, pH 7.4, containing 60 mM CF (mixed isomers; 
Sigma-Aldrich). The vesicles were sized using 200-nm polycarbonate ﬁ lters 
and separated from the extravesicular CF by dialysis. The ﬂ uorescence sig-
nal F was recorded after addition of mastoparan X and PCI at 37°C. In the 
case of pore formation, dequenching of the dye upon dilution into the me-
dium will increase the values above the initial value Fo. To determine the 
ﬂ uorescence signal for the maximally releasable amount of CF (Ft), the ves-
icles were solubilized using the detergent C12E8.
Fluorescence correlation spectroscopy
Giant unilamellar vesicles (GUV) were prepared from 1-palmitoyl, 2-linoleoyl 
species of PC and PE together with 5 mol% dipalmitoyl-PS. For determina-
tion of the translational diffusion coefﬁ cient DT, 10−4 mol% of DiD-C18 
 (Invitrogen) was added. The dispersed lipids were transferred to a cover-
glass chamber (Lab-Tek; Nalge Nunc), the formed GUV were allowed to 
settle for 20 min, and 9 nM Alexa 488–PCI was added. The ﬂ uorescence 
correlation spectroscopy measurements were performed in the autocorre-
lation mode with the ConfoCor 2 system (Carl Zeiss, Inc.) using either the 
488-nm line of an Ar-ion Laser or a 633-nm HeNe Laser (at 50–60 μW). 
The excitation light was reﬂ ected by a dichroic mirror (HFT 488/633; 
Carl Zeiss, Inc.) and focused onto the sample. The emitted ﬂ uorescence 
light was split by a second dichroic mirror (NFT 635; Carl Zeiss, Inc.), 
passed through two ﬁ lters (505–550 nm bandpass and 650 nm longpass 
ﬁ lter; Carl Zeiss, Inc.), and detected in two separate channels. In each 
case, out of plane ﬂ uorescence was reduced by a pinhole of 90-μm diameter. 
For analysis of the membrane interaction of PCI, the ﬂ uorescence correla-
tion spectroscopy focal spot was positioned near the center of the upper 
membrane of the GUV. For characterizing the diffusion properties of PCI 
in aqueous solution, the focus was moved to a position 20 μm above 
the  upper membrane. The data were evaluated by Levenberg-Marquardt 
 nonlinear least squares ﬁ tting to the appropriate model of the autocorrela-
tion function.
Pr3+ transfer into vesicles
LUV of a diameter of 200 nm were prepared by the extrusion method (see 
Translocation of PCI…) and Pr3+ was added to a ﬁ nal concentration of 
5.7 mM. The chemical shifts of the 31P signals from the phospholipids pre-
sent in the outer and inner leaﬂ et of the LUV were registered. NMR spectra 
were recorded with a spectrometer (400S; Varian Medical Systems).
Docking studies
Based on the crystal structure of cleaved PCI (Huntington et al., 2003), 
docking studies for PE binding were performed with the program Dock-
Vision. Because of the extreme ﬂ exibility of the PE ligand, the docking studies 
were initially performed on a straight 11-carbon chain fragment (gener-
ated using CORINA; Huntington et al., 2003) meant to represent a possi-
ble conformation of the fully saturated hydrocarbon chain of PE. The 
maximum ﬂ oating radius was set at 100 Å to ensure full coverage of PCI, 
and a total of 10,000 trials with a schedule of six conditions of 500 steps 
each was used in docking. The model of the PE–PCI complex using the 
1-palmitoyl, 2-linoleoyl species of PE was built in XtalView (Huntington et al., 
2003) and energy minimized using CNS (one cycle of 2,000 steps; Brunger 
et al., 1998).
Statistics
The mean values given are ± SD. The determinations were compared by 
one-way analysis of variance. Differences of P < 0.05 were considered to 
be signiﬁ cant.
Online supplemental material
Fig. S1 shows that inhibition of PCI decreases PE import into activated 
platelets. Fig. S2 indicates that uPCI added to HL-60 cells is incorporated 
into nuclear fractions of those cells. Fig. S3 shows that the PE-dependent in-
ternalization of PCI is also detected at low temperatures and under condi-
tions of extensive proteolysis of cell surface proteins. Fig. S4 provides 
results from molecular docking analyses indicating the presumed PE bind-
ing site in PCI. Online supplemental material is available at http://www
.jcb.org/cgi/content/full/jcb.200707165/DC1.
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